EDGAR Filing Documents for 0001279569-17-002214

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-17-002214

Filing Date

2017-11-14

Accepted

2017-11-14 16:03:56

Documents

Period of Report

2017-11-14

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tv478952_6k.htm	6-K	12910
2	EXHIBIT 99.1	tv478952_ex99-1.htm	EX-99.1	153712
3	EXHIBIT 99.2	tv478952_ex99-2.htm	EX-99.2	383163
4	EXHIBIT 99.3	tv478952_ex99-3.htm	EX-99.3	263078
5	EXHIBIT 99.4	tv478952_ex99-4.htm	EX-99.4	10645
6	EXHIBIT 99.5	tv478952_ex99-5.htm	EX-99.5	10811
7	GRAPHIC	tv478952_ex99-3img1.jpg	GRAPHIC	18212
	Complete submission text file	0001279569-17-002214.txt		860677

Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7

Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905

Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)